Business
Futura Medical Annual General Meeting Results
Futura Medical Annual General Meeting Results.
About this update from Futura Medical Plc
[{"type":"text","content":"\n\n \n22 June 2023\n Futura Medical plc\n(\"Futura\" or the \"Company\")\nFutura Medical Announces Annual General Meeting Results\n \n \nFutura Medical plc (AIM: FUM) (\"Futura\" or the \"Company\"), a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys® drug delivery technology currently focused on sexual health, today announces that at its Annual General Meeting, held today at 10:00am BST, the shareholders duly passed all resolutions.\n \nThe total number of votes received on each resolution were as follows:\n \n \n\n\n\n\n\n\nVoting For \n\n\nVoting Against \n\n\n\n\n\n\n\nNumber of votesi\n\n\n%\n\n\nNumber of votes\n\n\n%\n\n\nTotal Votes\n\n\n% ISC\n\n\nVotes withheldii\n\n\n\n\nResolution 1\n\n\nTo receive and adopt the annual report of the directors and the financial statements for the financial\nyear ended 31 December 2022 and the report of the appointed auditors thereon.\n\n\n69,770,830\n\n\n99.98%\n\n\n11,289\n\n\n0.02%\n\n\n69,782,119\n\n\n24.22%\n\n\n19,089\n\n\n\n\nResolution 2\n\n\nTo re-elect John Clarke as a Director of the Company, who retires by rotation in accordance with the\nCompany's articles of association.\n\n\n69,751,950\n\n\n99.96%\n\n\n26,170\n\n\n0.04%\n\n\n69,778,120\n\n\n24.22%\n\n\n23,089\n\n\n\n\nResolution 3\n\n\nTo re-appoint Grant Thornton UK LLP as auditor of the Company to hold office until the conclusion of\nthe next annual general meeting of the Company.\n\n\n69,717,388\n\n\n99.91%\n\n\n64,733\n\n\n0.09%\n\n\n69,782,121\n\n\n24.22%\n\n\n19,089\n\n\n\n\nResolution 4\n\n\nTo authorise the Directors to determine the remuneration of Grant Thornton UK LLP as auditor of the\nCompany.\n\n\n69,720,243\n\n\n99.91%\n\n\n61,879\n\n\n0.09%\n\n\n69,782,122\n\n\n24.22%\n\n\n19,089\n\n\n\n\nResolution 5\n\n\nTo authorise that the Directors of the Company are generally and unconditionally authorised for the purposes of section 551\nCompanies Act 2006 (the \"CA 2006\") to exercise all the powers of the Company to allot shares in the\nCompa...